flecainide has been researched along with Diffuse Parenchymal Lung Disease in 2 studies
Flecainide: A potent anti-arrhythmia agent, effective in a wide range of ventricular and atrial ARRHYTHMIAS and TACHYCARDIAS.
flecainide : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 2,5-bis(2,2,2-trifluoroethoxy)benzoic acid with the primary amino group of piperidin-2-ylmethylamine. An antiarrhythmic agent used (in the form of its acetate salt) to prevent and treat tachyarrhythmia (abnormal fast rhythm of the heart).
| Excerpt | Relevance | Reference |
|---|---|---|
| "Flecainide is a rare cause of hypersensitivity pneumonitis, and few cases have been reported." | 6.41 | Flecainide-associated pneumonitis with acute respiratory failure in a patient with the LEOPARD syndrome. ( Fuhrman, C; Perchet, H; Robain, A, 2000) |
| "Flecainide is a rare cause of hypersensitivity pneumonitis, and few cases have been reported." | 2.41 | Flecainide-associated pneumonitis with acute respiratory failure in a patient with the LEOPARD syndrome. ( Fuhrman, C; Perchet, H; Robain, A, 2000) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taieb, D | 1 |
| Chauveau, S | 1 |
| Khamis, W | 1 |
| de Montmollin, N | 1 |
| Sesé, L | 1 |
| Duchemann, B | 1 |
| Nunes, H | 1 |
| Uzunhan, Y | 1 |
| Robain, A | 1 |
| Perchet, H | 1 |
| Fuhrman, C | 1 |
1 review available for flecainide and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
Flecainide-associated pneumonitis with acute respiratory failure in a patient with the LEOPARD syndrome.
Topics: Abnormalities, Multiple; Acute Disease; Anti-Arrhythmia Agents; Flecainide; Heart Defects, Congenita | 2000 |
1 other study available for flecainide and Diffuse Parenchymal Lung Disease
| Article | Year |
|---|---|
[A case of systemic sclerosis].
Topics: Aged; Autoantibodies; Cystadenocarcinoma, Serous; Female; Flecainide; Humans; Lung Diseases, Interst | 2020 |